INCR: InterCure Ltd. - Summary | Jitta

InterCure Ltd.

ISR:INCR

Price
₪2.44
Loss Chance
54.1%
2.37JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
141 / 421
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (35)
Recent Business Performance (62)
Financial Strength (50)
Return to Shareholders (0)
Competitive Advantage (34)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Revenue and EarningEarning loss detected in 2025
Operating MarginInconsistent
SG&A to SalesIncreasing
Key Stats
Jitta Score
Jitta Line
2.37
100.00%
2.84
95.01%
Pharmaceuticals
0.43
100.00%
n/a
100.00%
1.14
100.00%
COMPANY DESCRIPTION
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company has a strategic alliance with Cannasoul R&D Ltd. for the research, development, and commercialization of evidence-based cannabis therapeutics. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.